Orthofix (OFIX) director Michael Finegan receives 20,721 deferred units
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Orthofix Medical Inc. director Michael Finegan reported receiving an award of 20,721 deferred stock units of common stock. These units vest in full on the first anniversary of the grant date, contingent on his continued service. Each deferred stock unit represents the right to receive one Orthofix common share, which will be delivered within 45 days after his service with the company ends. Following this award and previously reported positions, Finegan now holds a total of 81,617 Orthofix shares and deferred stock units, including 55,805 earlier deferred units and 3,505 shares acquired under Orthofix's Stock Purchase Plan.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Finegan Michael
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 20,721 | $0.00 | -- |
Holdings After Transaction:
Common Stock — 81,617 shares (Direct, null)
Footnotes (1)
- Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. Includes 55,805 previously reported deferred stock units and an aggregate of 3,505 shares acquired under Orthofix's Stock Purchase Plan ("Orthofix's SPP") on 10/31/2025 and 4/30/2026. Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5), and share acquisitions under the plan are exempt from Section 16(b).
Key Figures
Deferred stock units granted: 20,721 units
Total holdings after transaction: 81,617 shares/units
Previously reported deferred units: 55,805 units
+4 more
7 metrics
Deferred stock units granted
20,721 units
Award to director Michael Finegan on grant date
Total holdings after transaction
81,617 shares/units
Common stock and deferred stock units following award
Previously reported deferred units
55,805 units
Deferred stock units held before new grant
Shares from Stock Purchase Plan
3,505 shares
Acquired under Orthofix’s SPP on 10/31/2025 and 4/30/2026
Grant price per unit
$0.00
Compensation-related award, not open-market purchase
Vesting schedule
1-year cliff vesting
Units vest in full on first anniversary of grant
Settlement timing
Within 45 days
Conversion into common stock after termination of service
Key Terms
deferred stock units, Orthofix's Stock Purchase Plan, Rule 16b-3(b)(5), Section 16(b), +1 more
5 terms
deferred stock units financial
"Represents an award of deferred stock units that vest in full on the first anniversary of the grant date"
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Orthofix's Stock Purchase Plan financial
"Includes 55,805 previously reported deferred stock units and an aggregate of 3,505 shares acquired under Orthofix's Stock Purchase Plan"
Rule 16b-3(b)(5) regulatory
"Orthofix's SPP is a "Stock Purchase Plan" as defined in Rule 16b-3(b)(5)"
Section 16(b) regulatory
"share acquisitions under the plan are exempt from Section 16(b)"
A federal rule that requires company insiders—like officers, directors and large shareholders—to return any profits made from buying and selling the company’s stock within a six-month window. It matters to investors because it discourages short-term trades that could exploit non-public information and helps protect outside shareholders by creating a simple, enforceable way to recover unfair gains, much like a rule stopping someone from flipping a limited-edition item for quick profit after getting early access.
contingent right financial
"Each deferred stock unit represents a contingent right to receive one share of common stock"
FAQ
What did Orthofix (OFIX) director Michael Finegan report in this Form 4?
Michael Finegan reported receiving 20,721 deferred stock units of Orthofix common stock. These were granted at no cost as a compensation award, increasing his total reported holdings to 81,617 shares and units, including earlier deferred units and shares from the company’s stock purchase plan.
How do Michael Finegan’s new Orthofix (OFIX) deferred stock units vest?
The 20,721 deferred stock units vest in full on the first anniversary of the grant date. Vesting is conditioned on Finegan’s continued service with Orthofix through that date, aligning his compensation with ongoing board service over the coming year.
What are Michael Finegan’s total reported Orthofix (OFIX) holdings after this transaction?
After the award, Finegan’s total reported position is 81,617 Orthofix shares and deferred stock units. This includes the new 20,721-unit grant, 55,805 previously reported deferred stock units, and 3,505 shares acquired under Orthofix’s Stock Purchase Plan on two prior dates.
What is Orthofix’s Stock Purchase Plan mentioned in Michael Finegan’s Form 4?
Orthofix’s Stock Purchase Plan is described as a “Stock Purchase Plan” under Rule 16b-3(b)(5). The Form 4 notes that 3,505 shares were acquired under this plan and that acquisitions through it are exempt from Section 16(b) short-swing profit rules for insider transactions.
Was Michael Finegan’s Orthofix (OFIX) award an open-market stock purchase?
No, the Form 4 characterizes the transaction as a grant or award acquisition coded “A,” with a zero per-share price. This indicates compensation-related deferred stock units rather than an open-market stock purchase executed at a market price.